Funding Details
- Date Award
- May 13, 2024
- Vertical
- Human Health
- Funding URL
- View Funding Page
Company Info
- Organizations Involved
- None
- Founders
- Erika de Simone Molina, Emerson Moretto
- Company Description
- At Bioptamers, we spot the molecular differences between tumor cells and healthy cells and create personalized molecules to deliver chemo- and radio- immunotherapies. Our platform develops molecules that selectively bind to the patient’s cancer cells, allowing personalized precision therapies.
- Location
-
United States
- Coinvestors
- None
Links